1.
Regulation of Plasminogen Activator Inhibitor-1 Expression during 3T3-L1 Adipocytes Differentiation;
脂肪细胞分化过程中纤溶酶原激活剂抑制物-1基因的表达调控研究
2.
Plasminogen Activator Inhibitor-1 and Cardiovascular Diseases
纤溶酶原激活物抑制剂-1与心血管疾病
3.
Inhibitory effect of green tea polyphenols on plasminogen activator inhibitor-1 expression
绿茶多酚对纤溶酶原激活物抑制剂-1表达影响
4.
Cytokine-induced release of plasminogen activator inhibitor-1 by human pleural mesothelial cells
细胞因子诱导人胸膜细胞释放纤溶酶原激活物抑制剂-1的研究
5.
Relationship between Sepsis and a 4G/5G Polymorphism Within the Promoter Region of Plasminogen Activator Inhibitor-1 (PAI-1) Gene;
纤溶酶原激活物抑制剂-1基因启动子区4G/5G多态性与脓毒症发生发展的相关性
6.
The Correlation between 4G/5G Polymorphism in Promoter Region of PAI-1 Gene and Coronary Artery Disease;
纤溶酶原激活物抑制剂-1基因启动子区4G/5G多态性与冠心病的关系
7.
The Role of the Plasminogen Activator Inhibitor-1 in the Pathogenesis of Hepatic Fibrosis;
纤溶酶原激活物抑制剂-1在肝纤维化发生中的作用
8.
Research Progress of Plasminogen Activator Inhibitor One in Gestational Diabetes Mellitus
纤溶酶原激活物抑制剂-1（PAI-1）与妊娠期糖尿病的研究
9.
Relationship between plasminogen activator inhibitor 1 and neuroblastoma
纤溶酶原激活物抑制物1与神经母细胞瘤
10.
The expression of plasminogen activator inhibitor 1 (PAI 1) gene in human astrocytomasG
人脑星形细胞瘤纤溶酶原激活抑制因子1基因表达研究
11.
Association of plasminogen activator inhibitor-1 gene promoter 4G/5G genotype polymorphism with gestational diabetes
纤溶酶原激活物抑制因子1基因启动子区4G/5G多态性与妊娠糖尿病的相关性研究
12.
The Effect of Astragalus and Safflower Mixture on Expression of Plasminogen Activator Inhibitor 1 in Renal Tubulointerstitial Fibrosis in Rats with Unilateral Ureteral Obstruction;
芪红合剂对肾间质纤维化模型大鼠肾组织中纤溶酶原激活物抑制物-1表达的影响
13.
Plasma Concentrations Changes and Significance of Plasminogen Activator, Plasminogen Activator Receptor and Plasminogen Activator Inhibitor-1 in Chronic Glomerulonephritis and the Intervenient Research on Them;
慢性肾小球肾炎血浆纤溶酶原激活物及其受体和纤溶酶原激活物抑制剂的变化与干预研究
14.
The Changes of the Plasiminogen Activitor Inhibitor-1(PAI-1) in Patients with Coronary Heart Desease and It s Relationship to Clinical Factors;
冠心病患者血浆纤溶酶原激活剂抑制因子（PAI-1）的变化及其相关因素的研究
15.
Change and Implication of PAI-1 in Coronary Heart Disease Patients after Glucose Load
冠心病患者糖负荷后纤溶酶原激活物抑制物-1的变化及意义
16.
A Case of Deficiency of Plasma Plasminogen Activator Inhibitor 1, Its Diagnosis, Treatment and Study on Molecular Abnormality
遗传性纤溶酶原激活剂抑制物-1缺乏症的诊断、治疗及发病机理的研究
17.
The Study on the Effect of Tissue-type Plasminogen Activator and Its Inhibitor-1 on the Formation of Pulmonary Thromboembolism;
组织型纤溶酶原激活物及其抑制剂-1对肺血栓栓塞症形成影响的探讨
18.
Role of Thrombomodulin and Plasminogen Activator Inhibitor-1 in Diabetic Retinopathy;
血栓调节蛋白和纤溶酶原激活物抑制剂-1在糖尿病视网膜病变中的作用